Bio-Techne
TECH
576 hedge funds and large institutions have $8.84B invested in Bio-Techne in 2025 Q3 according to their latest regulatory filings, with 97 funds opening new positions, 214 increasing their positions, 185 reducing their positions, and 69 closing their positions.
46% more call options, than puts
Call options by funds: $29.5M | Put options by funds: $20.3M
41% more first-time investments, than exits
New positions opened: 97 | Existing positions closed: 69
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
16% more repeat investments, than reductions
Existing positions increased: 214 | Existing positions reduced: 185
8% more capital invested
Capital invested by funds: $8.17B → $8.84B (+$666M)
4% more funds holding
Funds holding: 554 → 576 (+22)
0.87% more ownership
Funds ownership: 101.2% → 102.07% (+0.87%)
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$294M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$121M |
| 3 |
Millennium Management
New York
|
-$76.9M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$51.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$40.5M |
TECH Hedge Fund Activity: Q3 2025 in Review
576 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q3 2025, worth a combined $8.84B — up 8.2% from $8.17B a quarter earlier.
Buyers outnumbered sellers: 97 funds opened new TECH positions and 69 closed out — a net gain of 28 holders — while 214 added to existing stakes and 185 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $213M. The largest seller was T. Rowe Price Associates, cutting an estimated $294M.
- 576 institutional investors held Bio-Techne (TECH) as of Q3 2025, up from 554 in Q2 2025.
- Funds reported $8.84B of Bio-Techne stock for Q3 2025, up 8.2% quarter-over-quarter.
- 97 funds opened new Bio-Techne positions in Q3 2025 and 69 closed out, a net change of +28 holders.
- The largest Bio-Techne buyer in Q3 2025 was Wellington Management Group, an estimated $213M added.
- The largest Bio-Techne seller in Q3 2025 was T. Rowe Price Associates, an estimated $294M sold.
Based on aggregated 13F filings for Q3 2025.